RYJSX
Price
$144.68
Change
-$0.25 (-0.17%)
Updated
Jul 3 closing price
Net Assets
1.21M
RYVYX
Price
$607.60
Change
+$11.57 (+1.94%)
Updated
Jul 3 closing price
Net Assets
1.14B
Interact to see
Advertisement

RYJSX vs RYVYX

Header iconRYJSX vs RYVYX Comparison
Open Charts RYJSX vs RYVYXBanner chart's image
Rydex Japan 2x Strategy A
Price$144.68
Change-$0.25 (-0.17%)
VolumeN/A
Net Assets1.21M
Rydex NASDAQ-100® 2x Strategy H
Price$607.60
Change+$11.57 (+1.94%)
VolumeN/A
Net Assets1.14B
RYJSX vs RYVYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RYJSX vs. RYVYX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYJSX is a Hold and RYVYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.14B vs. RYJSX (1.21M). RYJSX pays higher dividends than RYVYX: RYJSX (3.76) vs RYVYX (0.00). RYJSX was incepted earlier than RYVYX: RYJSX (17 years) vs RYVYX (25 years). RYVYX (2.00) is less costly to investors than RYJSX (1.57). RYVYX is a more actively managed with annual turnover of: 392.00 vs. RYJSX (1.54). RYJSX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYJSX annual gain was more profitable for investors over the last year : 9.29 vs. RYVYX (5.74). RYVYX return over 5 years is better than : 146.73 vs. RYJSX (27.31).
RYJSXRYVYXRYJSX / RYVYX
Total Expense Ratio1.541.8981%
Annual Report Gross Expense Ratio1.572.0079%
Fund Existence17 years25 years-
Gain YTD16.7478.294202%
Front Load5%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21M1.14B0%
Annual Yield % from dividends3.760.00-
Returns for 1 year9.295.74162%
Returns for 3 years54.36163.7233%
Returns for 5 years27.31146.7319%
Returns for 10 years66.55679.1210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAN5.800.09
+1.58%
Manhattan Bridge Capital
ARCT13.780.16
+1.17%
Arcturus Therapeutics Holdings
VLYPO24.680.17
+0.71%
Valley National Bancorp
TFII93.98-0.15
-0.16%
TFI International
VRTS199.10-1.61
-0.80%
Virtus Investment Partners